Synthorx Inc.

Cancer is the central therapeutic focus, with research directed toward advanced solid tumors and metastatic disease. The sponsor’s clinical activity in this area reflects interest in treatment approaches for difficult-to-manage malignancies.

• Solid tumors
• Metastatic cancer
• Antitumor activity

Clinical investigation also includes assessment of objective response in patients with refractory disease, indicating a focus on measurable tumor control in the setting of advanced malignancy.